Last reviewed · How we verify
Levamlodipine Maleate (Xuanning) or Amlodipine Besylate (Norvasc) for Treatment of Hypertension: A Comparative Effectiveness Research (LEADER)
The purpose of this study is to determine whether the effectiveness of levamlodipine maleate (xuanning) is noninferior to amlodipine besylate (Norvasc) in treatment of hypertension in a Chinese primary hypertension population.
Details
| Lead sponsor | Peking University First Hospital |
|---|---|
| Status | UNKNOWN |
| Enrolment | 10000 |
| Start date | 2013-02 |
| Completion | 2015-12 |
Conditions
- Primary Hypertension
Primary outcomes
- incidence of composite cardiovascular and cerebrovascular endpoints — 2 years
- quality of blood pressure control — 2 years
Countries
China